102 related articles for article (PubMed ID: 19960480)
1. Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation.
Liang S; Xu Y; Shen G; Liu Q; Zhao X; Xu Z; Xie X; Gong F; Li R; Wei Y
Electrophoresis; 2009 Dec; 30(23):4152-62. PubMed ID: 19960480
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and methylation status of 14-3-3sigma in human renal carcinoma tissues.
Liang S; Xu Y; Shen G; Zhao X; Zhou J; Li X; Gong F; Ling B; Fang L; Huang C; Wei Y
IUBMB Life; 2008 Aug; 60(8):534-40. PubMed ID: 18548556
[TBL] [Abstract][Full Text] [Related]
3. Application of the SILAC (stable isotope labelling with amino acids in cell culture) technique in quantitative comparisons for tissue proteome expression.
Xu Y; Liang S; Shen G; Xu X; Liu Q; Xu Z; Gong F; Tang M; Wei Y
Biotechnol Appl Biochem; 2009 Jul; 54(1):11-20. PubMed ID: 19250064
[TBL] [Abstract][Full Text] [Related]
4. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.
Perego RA; Bianchi C; Corizzato M; Eroini B; Torsello B; Valsecchi C; Di Fonzo A; Cordani N; Favini P; Ferrero S; Pitto M; Sarto C; Magni F; Rocco F; Mocarelli P
J Proteome Res; 2005; 4(5):1503-10. PubMed ID: 16212400
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
6. Isoform-specific expression and characterization of 14-3-3 proteins in human glioma tissues discovered by stable isotope labeling with amino acids in cell culture-based proteomic analysis.
Liang S; Shen G; Liu Q; Xu Y; Zhou L; Xiao S; Xu Z; Gong F; You C; Wei Y
Proteomics Clin Appl; 2009 Jun; 3(6):743-53. PubMed ID: 21136983
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
Perathoner A; Pirkebner D; Brandacher G; Spizzo G; Stadlmann S; Obrist P; Margreiter R; Amberger A
Clin Cancer Res; 2005 May; 11(9):3274-9. PubMed ID: 15867223
[TBL] [Abstract][Full Text] [Related]
8. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma.
Craven RA; Stanley AJ; Hanrahan S; Dods J; Unwin R; Totty N; Harnden P; Eardley I; Selby PJ; Banks RE
Proteomics; 2006 May; 6(9):2853-64. PubMed ID: 16596713
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
[TBL] [Abstract][Full Text] [Related]
11. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression.
Gu B; Ding Q; Xia G; Fang Z
Oncol Rep; 2009 Mar; 21(3):635-40. PubMed ID: 19212621
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
[TBL] [Abstract][Full Text] [Related]
13. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
[TBL] [Abstract][Full Text] [Related]
15. Isoform-specific expression of 14-3-3 proteins in human astrocytoma.
Yang X; Cao W; Lin H; Zhang W; Lin W; Cao L; Zhen H; Huo J; Zhang X
J Neurol Sci; 2009 Jan; 276(1-2):54-9. PubMed ID: 18851859
[TBL] [Abstract][Full Text] [Related]
16. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 isoforms in renal cell carcinoma.
Song W; Huo SW; Lü JJ; Liu Z; Fang XL; Jin XB; Yuan MZ
Chin Med J (Engl); 2009 Apr; 122(8):921-6. PubMed ID: 19493415
[TBL] [Abstract][Full Text] [Related]
18. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
19. [Beta-catenin and its mRNA in renal cell carcinoma].
Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):37-9. PubMed ID: 11831984
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma.
Kurose K; Sakaguchi M; Nasu Y; Ebara S; Kaku H; Kariyama R; Arao Y; Miyazaki M; Tsushima T; Namba M; Kumon H; Huh NH
J Urol; 2004 Mar; 171(3):1314-8. PubMed ID: 14767340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
